Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)
Clinical trial NCT04181723 · COMPLETED
Trial details
- NCT number
- NCT04181723
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2021-10-28
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.